[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364181-105":59,"doc-detail-364181-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","obesity-driven-adipokine-signaling-in-breast-cancer-review-article-mechanistic-insights-therapeutic-challenges-and-opportunities-for-precision-oncology","Obesity-driven adipokine signaling in breast cancer - Review article: mechanistic insights, therapeutic challenges, and opportunities for precision oncology","","Reviewing current evidence on breast cancer, this article analyzes how obesity reshapes the tumor microenvironment through adipokine dysregulation driven by dysfunctional adipocytes and macrophage alterations. It links obesity-associated signaling changes to cancer-promoting pathways that support proliferation, survival, inflammation, metastasis, and resistance to conventional therapies. The review highlights key mechanistic knowledge gaps and discusses precision-oncology opportunities to improve treatment personalization for obese patients.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/obesity-driven-adipokine-signaling-in-breast-cancer-review-article-mechanistic-insights-therapeutic-challenges-and-opportunities-for-precision-oncology/364181/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/obesity-driven-adipokine-signaling-in-breast-cancer-review-article-mechanistic-insights-therapeutic-challenges-and-opportunities-for-precision-oncology/364181.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does obesity contribute to breast cancer progression according to the review?","Question",{"text":112,"@type":113},"Obesity promotes tumor growth by disrupting adipokine production and activating cancer-promoting pathways. It also markedly alters the breast cancer microenvironment via dysfunctional adipocytes and macrophage changes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which signaling pathways are highlighted as being activated by obesity-associated adipokine changes?",{"text":117,"@type":113},"The review emphasizes oncogenic pathways including JAK, STAT3, NF-κB, and Akt. These pathways drive breast cancer growth and are linked to adipokine-mediated dysregulation.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic challenges and opportunities are discussed for precision oncology in obese patients?",{"text":121,"@type":113},"The article focuses on therapeutic challenges stemming from microenvironment-driven resistance to traditional treatments. It identifies knowledge gaps and argues that clarifying obesity-altered tumor biology is essential to develop more personalized, effective therapies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364181,1790190735,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","pISSN 2383-7837 ∙ eISSN 2383-7845  \nREVIEW ARTICLE  \nJournal of Pathology and Translational Medicine 2026; 60: 476-492 [https://doi.org/10.4132/jptm.2026.06.30](https://doi.org/10.4132/jptm.2026.06.30)  \nObesity-driven adipokine signaling in breast cancer: mechanistic insights, therapeutic challenges, and opportunities for precision oncology  \nVadakke Kunnumma Soonu1, Praveen Kumar Shenoy2, Valiyaparampil Gopi Deepak Roshan3, Vipin Gopinath3, Krishnan Sreejith1  \n1Department of Biotechnology and Microbiology, Dr. Janaki Ammal Campus, Kannur University, Thalassery, India  \n2Division of Medical Oncology, Department of Clinical Hematology and Medical Oncology, Malabar Cancer Centre, Thalassery, India  \n3Division of Genetics and Cytogenetics, Department of Clinical Laboratory Service and Translational Research, Malabar Cancer Centre, Thalassery, India  \nBreast cancer is the leading cause of illness and death among women worldwide, with more than 2.3 million new cases diagnosed each year. The incidence and fatality rates are steadily increasing, notably in Asian countries. Obesity has been established as a major and growing risk factor for breast cancer progression. The World Health Organization reports that adult obesity rates have doubled since 1990. Obesity promotes tumor growth by inhibiting adipokine production and activating cancer-promoting pathways. In obese people, the microenvironment surrounding breast cancer cells is drastically altered. This is mostly due to the malfunctioning of adipocytes (fat cells) and macrophages. These defective cells' adipokines alter signaling pathways required for cancer cell proliferation, survival, and inflammation. This dysregulation has a significant role in tumor development, metastasis, and resistance to traditional cancer treatments, particularly in obese patients. This review highlights the role of adipokines in breast cancer, with a focus on disease progression, therapeutic challenges, and knowledge gaps. Clarifying how obesity alters tumor biology is key to advancing personalized and effective treatments for obese patients.  \nKeywords: Obesity; Breast neoplasms; Adipokines  \nINTRODUCTION  \nBreast cancer is the most frequently diagnosed malignancy in women, with more than 2.3 million new cases reported annually. It continues to be a leading contributor to global cancer-related morbidity and mortality [ 1]. An increasing incidence and mortality have been reported in Asian countries [2] . Obesity is on the rise, and studies suggest that breast cancer patients with obesity may have a reduced response to treatment. However, this remains debatable and is not currently factored into treatment decisions due to gaps in scientific understanding. Breast cancer risk and outcomes are influenced by multiple factors, including age, family history, genetic predisposition, obesity,  \nalcohol use, and smoking. While obesity is considered a modifiable risk factor, some studies report contradictory findings [3]. Obesity is characterized by excess fat buildup and malfunctioning adipocytes that produce aberrant adipokines into the tumor microenvironment, activating oncogenic pathways such as JAK, signal transducer and activator of transcription 3 (STAT3), nuclear factor кB (NF-κB), and Akt, which promote breast cancer growth [4,5] .  \nThe tumor microenvironment plays a key role in cancer progression by supporting cell proliferation, angiogenesis, and survival [6] . In breast cancer, it is composed mainly of adipocytes, macrophages, and tumor cells. Among these, adipocytes are the most abundant and metabolically active, particularly in obese  \nReceived: April 6, 2026 Revised: June 11, 2026 Accepted: June 30, 2026  \nCorresponding Author: KrishnanSreejith, PhD  \nDepartment of Biotechnology and Microbiology, Dr. JanakiAmmal Campus, Kannur University, Thalassery, Kerala-670661, India Tel: +91-9446870675, Fax: +91-4972711460, [E-mail: sreejithkrishnan@hotmail.com](E-mail: sreejithkrishnan@hotmail.com)  \nThis is","cbCaivU4Wjv6X8It","https://ap.wps.com/l/cbCaivU4Wjv6X8It","pdf",2221037,17,"English","# Introduction\n# Adipokines at the Crossroads of Obesity and Breast Cancer\n## Tumor microenvironment dysregulation in obesity\n## Treatment resistance and clinical implications","[{\"question\":\"How does obesity contribute to breast cancer progression according to the review?\",\"answer\":\"Obesity promotes tumor growth by disrupting adipokine production and activating cancer-promoting pathways. It also markedly alters the breast cancer microenvironment via dysfunctional adipocytes and macrophage changes.\"},{\"question\":\"Which signaling pathways are highlighted as being activated by obesity-associated adipokine changes?\",\"answer\":\"The review emphasizes oncogenic pathways including JAK, STAT3, NF-κB, and Akt. These pathways drive breast cancer growth and are linked to adipokine-mediated dysregulation.\"},{\"question\":\"What therapeutic challenges and opportunities are discussed for precision oncology in obese patients?\",\"answer\":\"The article focuses on therapeutic challenges stemming from microenvironment-driven resistance to traditional treatments. It identifies knowledge gaps and argues that clarifying obesity-altered tumor biology is essential to develop more personalized, effective therapies.\"}]","Obesity-driven adipokine signaling in breast cancer - Review article: mechanistic insights, therapeutic challenges, and opportunities for precision oncology | PDF",1790156224,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03297b03129e01db73442f1cf82c6e55.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/388dd7fa496a804049587f3983361d87.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8147f54c491443e5c2a3fdd0aff16aa1.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a95abd95ab5c8cb03f809b77866da24b.webp",980,1306]